Best for GLP-1: you want larger, sustained weight loss under ongoing provider care, especially if phentermine stalled or you regained after stopping it.
Best for phentermine: you want a short-term jumpstart, have a lower BMI, and prefer a brief course rather than continued therapy.
The gap comes down to how each drug works and how long you take it. Semaglutide and tirzepatide reduce appetite over months, so the weight loss keeps building. A 2021 FDA approval cleared semaglutide for chronic weight management alongside diet and exercise, which is why providers keep patients on it. Phentermine curbs appetite quickly, but the FDA capped it at 12 weeks in 1959, so its benefit plateaus by design.
Semaglutide works gradually because you titrate the dose upward over several months, and the weight loss follows that same slow curve rather than arriving all at once. Providers start you low, usually 0.25 mg weekly, and step the dose up every four weeks to reduce nausea and let your body adjust. Here is what the trajectory typically looks like, grounded in the STEP-trial dosing schedule and outcomes.
The difference from phentermine is structural. Phentermine front-loads its results in the first weeks, then stops at the 12-week FDA limit before your body has finished responding. Semaglutide keeps working through months 6 and 12 precisely because you stay on it under provider supervision, so the largest gains come after the point where phentermine would already be behind you.
One honest note on the compounded medications. Compounded semaglutide is not itself FDA-approved as a standalone product. The active ingredient matches FDA-approved Ozempic and Wegovy, and licensed pharmacies prepare the compounded version under provider oversight. That distinction matters, and any provider worth trusting will state it plainly rather than blur it. The clinical evidence above comes from studies of brand-name semaglutide, and the same active ingredient is what your compounded prescription contains.
Phentermine works, and it works quickly. Most people lose about 5 to 10 percent of their body weight in the first few months, which puts it roughly on par with a dedicated diet-and-exercise program. As an appetite suppressant, it curbs hunger through a stimulant effect, and that effect shows up fast. The limitation isn't whether phentermine helps. It's how long you can safely rely on it.
The FDA approved phentermine for weight loss in 1959 and capped treatment at 12 weeks or less. Phentermine is a Schedule IV controlled substance, and that classification is the reason behind the duration cap. Its stimulant mechanism carries a real risk of tolerance and dependence, so the same effect that suppresses your appetite early on tends to fade with continued use. The 12-week window exists to limit that risk, not to punish patients.
In practice, prescribing runs longer than the label suggests. A 2019 observational study in Obesity, drawing on records from about 14,000 patients across eight health systems, found that 3 in 10 users stayed on phentermine beyond three months off-label, and long-term users kept off more than 7 percent of their weight at two years. So longer use can extend the benefit for some people.
The same study flagged a harder truth. About one-third of patients were non-responders, losing less than 3 percent of body weight in the first three months. These patients are advised to stop, because the drug is unlikely to help them further. Phentermine offers a strong, front-loaded start for the right person, but its benefit plateaus, and the medication was never built to carry you through years of maintenance.
Side effects separate these two medications as sharply as their results, because they act on different systems. GLP-1 medications slow digestion and signal fullness, so their side effects concentrate in the gut. Phentermine stimulates the central nervous system to suppress appetite, so its side effects show up as stimulant-type symptoms.
GLP-1 medications (semaglutide, tirzepatide) most commonly cause:
These effects tend to be mild to moderate, and they lessen over time as your body adjusts. In the 2024 STEP UP trial, researchers reported that adverse events were mostly gastrointestinal and mild to moderate, easing as treatment continued.
Phentermine most commonly causes:
Duration of use shapes how you experience each of these. Phentermine's stimulant effects often show up early and are one reason the FDA capped standard use at 12 weeks, so you meet them fast and stop before your body settles into them. GLP-1 nausea works the opposite way. You feel it most at the start, then it fades over months of steady, provider-guided dosing, which is why the therapy is built to continue.
Phentermine tends to fit patients who want a short, focused jumpstart. If your BMI sits in the lower ranges and you respond quickly, a 12-week course can give you real early momentum. The 2019 Kaiser Permanente cohort of about 14,000 users found that patients who lost at least 3% of their body weight by three months tended to see the most success, while roughly one-third lost less than 3% and were unlikely to benefit from continuing (KPWHRI). Phentermine works best when you already have a clear stopping point and a plan for what comes after.
A GLP-1 medication fits you better if you want larger, sustained loss under ongoing provider care. Semaglutide 2.4 mg produced about 15.6% average weight loss at 72 weeks in the STEP UP trial, several times what phentermine typically delivers short-term (Applied Clinical Trials Online). GLP-1s also make sense if phentermine stopped working for you, if you plateaued, or if the weight came back after your course ended. The medication keeps working as long as you stay on it, so it suits people managing weight as a long-term condition rather than a single sprint.
One truth applies to both. Stopping either medication without a maintenance plan commonly leads to regain, because neither drug rewires your metabolism permanently. Lasting results come from a structured program with real provider oversight that helps you transition off the medication or into a maintenance dose deliberately, not from the drug alone.
The sustained weight loss described above depends on structure, and Optima Tyler's semaglutide program gives you that structure for $249 every 10 weeks. That price is all-inclusive. It covers the medication, the supplies, your consultation, and discreet home delivery. There is no insurance to file, no membership, and no hidden fees. You pay for a fixed-duration, vial-based program, and provider-guided dosing determines how long each vial lasts.
You also get a customized dosing chart, a PDF that shows your weekly units so you always know exactly what to take. Real licensed nurse practitioners own and run the practice from Tyler, and the same clinicians guide you from your first consult through follow-up. You can visit in person in East Texas or use telehealth anywhere in the state.
One point on the medication itself. Optima's compounded semaglutide is not FDA-approved as a standalone product. Its active ingredient is the same as FDA-approved Ozempic and Wegovy, and it is prepared by licensed pharmacies under provider oversight. Being clear about that distinction is part of how we work.
If you have tried phentermine and hit a plateau, or you want larger, provider-managed results that hold, a GLP-1 program is built for that goal. You don't fail diets. Diets fail you.
Ready to start? Call (903) 459-6864 or book your consultation to talk with a provider about whether semaglutide fits your health and your goals.
Can I switch from phentermine to a GLP-1 medication? Yes, many patients move to a GLP-1 after phentermine's 12-week course ends or after they plateau. At Optima Tyler, a nurse practitioner reviews your history and guides the transition with a customized dosing chart. Switching lets you pursue larger, sustained weight loss under ongoing provider oversight rather than restarting a short-term stimulant.
What is the average weight loss timeline on Ozempic? Semaglutide works gradually as your dose steps up over several months. In the STEP UP trial, adults on the 2.4 mg dose lost about 15.6% of their body weight over 72 weeks using the treatment-policy measure (Applied Clinical Trials Online). Most people see steady loss through months three, six, and twelve rather than a fast early drop.
Is compounded semaglutide FDA-approved? No, compounded semaglutide is not itself FDA-approved as a standalone product. Its active ingredient matches FDA-approved Ozempic and Wegovy, and licensed pharmacies prepare the compounded version. Optima Tyler's nurse practitioners prescribe it off-label with the same clinical oversight you would expect from any weight-loss medication.
How much weight can I keep off long-term? Long-term results depend on staying on treatment or having a maintenance plan. A 2019 study in Obesity found phentermine users who continued past a year kept off more than 7% of baseline weight at two years (KPWHRI). Stopping either medication without a plan commonly leads to regain, so provider-guided maintenance matters.